Marshall Wace’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,873,310
Closed -$2.25M 3183
2023
Q1
$2.25M Buy
+1,873,310
New +$4.17M ﹤0.01% 1391
2022
Q3
Sell
-447,360
Closed -$1.01M 3960
2022
Q2
$1.01M Buy
+447,360
New +$1.67M ﹤0.01% 2427
2020
Q2
Sell
-12,492
Closed -$44K 2055
2020
Q1
$44K Sell
12,492
-7,747
-38% -$65.6K ﹤0.01% 1452
2019
Q4
$214K Buy
+20,239
New +$180K ﹤0.01% 1330
2017
Q1
Sell
-26,974
Closed -$678K 827
2016
Q4
$678K Sell
26,974
-111,699
-81% -$2.63M ﹤0.01% 811
2016
Q3
$3.44M Buy
+138,673
New +$3.68M 0.02% 485

Other funds holding DBD

Marshall Wace's DBD Position: Q2 2023 in Review

Marshall Wace sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 1,873,310 shares — an estimated $2.25M sold.

Marshall Wace first reported a position in DBD in Q3 2016 and held it in 6 quarters. The position peaked at $3.44M in Q3 2016. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Marshall Wace reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Marshall Wace sold 1,873,310 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $2.25M.
  • Marshall Wace first reported a position in Diebold Nixdorf Incorporated in Q3 2016 and held it in 6 quarters.
  • Marshall Wace's Diebold Nixdorf Incorporated position peaked at $3.44M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.